Designing novel regenerative tissue constructs requires examination of the necessary components of native tissues and their cellular niches to facilitate regeneration of skin/bone indistinguishable functionally and structurally from developmentally native tissue [1] . Using a variety of microscopy techniques including environmental scanning electron microscopy (ESEM), energy dispersive spectroscopy (EDS), second harmonic imaging (SHG), third harmonic imaging (THG), fluorescence lifetime imaging (FLIM), confocal, histology, immunohistochemistry (IHC), atomic force microscopy (AFM), and digital single lens reflex (DSLR) -tissues are imaged to determine correlative ultrastructural and cellular features within native and treated tissues [2] . Cross comparison of various modalities provides content specific data with clinical and translational applicability [3] . Donor native tissue specimens were obtained and interrogated through the various imaging modalities before and after our processing methods at an FDA-registered manufacturing facility to fully characterize their inherent properties. Whole mount imaging was completed using ESEM, SHG, THG, DSLR, EDS and confocal microscopes on excised formalin fixed tissues. Contrast media and clearing approaches were used to improve structural contrast and identify and characterize cellular populations. Native skin and bone and their respective constructs were paraffin embedded and sectioned in preparation for histology. Downstream immunological staining, ESEM, SHG, and AFM were performed to further elucidate the microarchitecture features and content of the treated and control specimen. The imaging results were correlated with in vitro and in vivo study outcomes to identify which processing formulations best recapitulated the properties of native skin and bone. Our methodology demonstrates that multimodal correlative microscopy-based investigations can be effectively applied to optimize regenerative product development. 
